Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
34837 | 60 | 25.1 | 56% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | UNITE PHARMACOEPIDEMIOL EA 3696 | Address | 1 | 50% | 2% | 1 |
2 | BLOOD POTASSIUM | Author keyword | 0 | 33% | 2% | 1 |
3 | HYPERGLUCAGONAEMIA | Author keyword | 0 | 33% | 2% | 1 |
4 | MYOCARDIAL INFARCT REGISTRY | Address | 0 | 33% | 2% | 1 |
5 | OSWALDO RAMOS FDN | Address | 0 | 33% | 2% | 1 |
6 | RUI JIN HOSPE SHANGHAI UNIV | Address | 0 | 33% | 2% | 1 |
7 | ENDOCRINE METAB DISMINIST HLTH | Address | 0 | 25% | 2% | 1 |
8 | NON TRADITIONAL RISK FACTORS | Author keyword | 0 | 25% | 2% | 1 |
9 | POTASSIUM LEVEL | Author keyword | 0 | 20% | 2% | 1 |
10 | PREVENT EPIDEMIOL CLIN | Address | 0 | 20% | 2% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BODY POTASSIUM | 0 | 13% | 3% | 2 |
2 | NONSELECTIVE BETA BLOCKERS | 0 | 10% | 2% | 1 |
Journals |
Reviews |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UNITE PHARMACOEPIDEMIOL EA 3696 | 1 | 50% | 1.7% | 1 |
2 | MYOCARDIAL INFARCT REGISTRY | 0 | 33% | 1.7% | 1 |
3 | OSWALDO RAMOS FDN | 0 | 33% | 1.7% | 1 |
4 | RUI JIN HOSPE SHANGHAI UNIV | 0 | 33% | 1.7% | 1 |
5 | ENDOCRINE METAB DISMINIST HLTH | 0 | 25% | 1.7% | 1 |
6 | PREVENT EPIDEMIOL CLIN | 0 | 20% | 1.7% | 1 |
7 | SHANGHAI CLIN ENDOCRINE METAB DIS ENDO | 0 | 20% | 1.7% | 1 |
8 | MINIST HLTHRUI JIN HOSP MED | 0 | 14% | 1.7% | 1 |
9 | RUI JIN HOSPSHANGHAI ENDOCRINE METAB DIS | 0 | 14% | 1.7% | 1 |
10 | KAISER PERMANENTE GEORGIA | 0 | 11% | 1.7% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000208434 | TRICEPS SKINFOLD//OESTROPROGESTATIVE// |
2 | 0.0000179248 | ICI 206 970//POTASSIUM BLOOD//EUKALEMIC |
3 | 0.0000148698 | HYPERINSULINEMIA//SUGAR INDUCED HYPERTENSION//ATHEROSCLEROSIS METAB CLIN NUTR |
4 | 0.0000137265 | AMIDOLYSIS//ELASTASE ALPHA1 PROTEINASE INHIBITOR//CLOT LYSIS ASSAY |
5 | 0.0000135995 | SYMPATHOMIMETIC AMINES//IDIOPATHIC EDEMA//SYMPATHETIC HYPOFUNCTION |
6 | 0.0000111919 | COLD TARGET COMPETITION//COMPLEMENT DISTRIBUTION//DEFORMABILITY OF RED CELLS |
7 | 0.0000106458 | INDAPAMIDE//CLIN NUTR METAB DIS//PHARMACOL PHYSIOPATHOL CARDIOVASC |
8 | 0.0000097113 | DIHYDROPYRIDINE TYPE CALCIUM CHANNEL BLOCKER//ETAFTORON//HOSP XIAMEN AFFILIATED 1 |
9 | 0.0000096689 | TELMISARTAN//ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER//CLIN TRIAL MANAGEMENTITABASHI KU |
10 | 0.0000093006 | ZENTRALBLATT FUR BAKTERIOLOGIE MIKROBIOLOGIE UND HYGIENE SERIE B-UMWELTHYGIENE KRANKENHAUSHYGIENE ARBEITSHYGI//AMMONIFYING BACTERIA//AINP SOIL BIO ERS BIOFERTILIZERS |